Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christelle Rodrigues

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pharmaceutical Research|June 2, 2021
Conditional Non-parametric Bootstrap for Non-linear Mixed Effect ModelsEmmanuelle Comets, Christelle Rodrigues, Vincent Jullien, et al.
European Journal of Clinical Pharmacology|March 23, 2018
A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsyChristelle Rodrigues, Stéphanie Chhun, Catherine Chiron, et al.
Epilepsy Research|January 15, 2019
Pharmacokinetic evaluation of vigabatrin dose for the treatment of refractory focal seizures in children using adult and pediatric dataChristelle Rodrigues, Catherine Chiron, Marwa Ounissi, et al.
British Journal of Clinical Pharmacology|August 4, 2017
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic childrenChristelle Rodrigues, Catherine Chiron, Elisabeth Rey, et al.
Biometrical Journal. Biometrische Zeitschrift|October 27, 2023
Incorporation of healthy volunteers data on receptor occupancy into a phase II proof-of-concept trial using a Bayesian dynamic borrowing designFulvio Di Stefano, Christelle Rodrigues, Stephanie Galtier, et al.
Clinical Pharmacokinetics|August 19, 2017
Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination TherapySophie Peigné, Stéphanie Chhun, Michel Tod, et al.
Journal of Clinical Pharmacology|September 8, 2018
Proposition of a Minimal Effective Dose of Vigabatrin for the Treatment of Infantile Spasms Using Pediatric and Adult Pharmacokinetic DataMarwa Ounissi, Christelle Rodrigues, Hugues Bienayme, et al.
Journal for Immunotherapy of Cancer|March 13, 2026
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancerFrancois Ghiringhelli, Richard Kim, Teresa Macarulla, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmaceutical Research|June 2, 2021
Conditional Non-parametric Bootstrap for Non-linear Mixed Effect ModelsEmmanuelle Comets, Christelle Rodrigues, Vincent Jullien, et al.
European Journal of Clinical Pharmacology|March 23, 2018
A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsyChristelle Rodrigues, Stéphanie Chhun, Catherine Chiron, et al.
Epilepsy Research|January 15, 2019
Pharmacokinetic evaluation of vigabatrin dose for the treatment of refractory focal seizures in children using adult and pediatric dataChristelle Rodrigues, Catherine Chiron, Marwa Ounissi, et al.
British Journal of Clinical Pharmacology|August 4, 2017
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic childrenChristelle Rodrigues, Catherine Chiron, Elisabeth Rey, et al.
Biometrical Journal. Biometrische Zeitschrift|October 27, 2023
Incorporation of healthy volunteers data on receptor occupancy into a phase II proof-of-concept trial using a Bayesian dynamic borrowing designFulvio Di Stefano, Christelle Rodrigues, Stephanie Galtier, et al.
Clinical Pharmacokinetics|August 19, 2017
Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination TherapySophie Peigné, Stéphanie Chhun, Michel Tod, et al.
Journal of Clinical Pharmacology|September 8, 2018
Proposition of a Minimal Effective Dose of Vigabatrin for the Treatment of Infantile Spasms Using Pediatric and Adult Pharmacokinetic DataMarwa Ounissi, Christelle Rodrigues, Hugues Bienayme, et al.
Journal for Immunotherapy of Cancer|March 13, 2026
Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancerFrancois Ghiringhelli, Richard Kim, Teresa Macarulla, et al.
Pageof 1